Combigene AB (COMBI) — Capital Reinvestment Ratio
Combigene AB (COMBI) has a Capital Reinvestment Ratio of 0.01x as of December 2021, meaning it reinvests 0% of its operating cash flow (Skr22.11 Million) in capital expenditures (Skr147.73K). See how leveraged is Combigene AB's balance sheet to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Combigene AB Capital Reinvestment Ratio (2018–2021)
This chart tracks Combigene AB's Capital Reinvestment Ratio across 2 annual periods. Check Combigene AB total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Combigene AB (2018–2021)
Year-by-year Capital Reinvestment Ratio for Combigene AB from 2018 to 2021. For live market cap and broader valuation context, see COMBI stock market capitalisation.
| Year | Reinvestment Ratio | Operating CF (SEK) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2021 | 0.01x | Skr22.11 Million | Skr147.73K | ▼ -99.6% |
| 2018 | 1.89x | Skr227.60K | Skr430.20K | — |